Biogen's revenue and net income 2007-2017

Biogen's revenue and net income from 2007 to 2017 (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data displays the revenue and net income of biotechnology company Biogen Idec from 2007 to 2017. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer. In 2017, Biogen Idec generated revenues worth around 12.3 billion USD.

2007 3171.6 579.8
2008 4097.5 790.1
2009 4377.3 977.1
2010 4716.4 898.6
2011 5048.6 1266.7
2012 5516.5 1380
2013 6932.2 1862.3
2014 9703.3 2941.5
2015 10763.8 3593.2
2016 11448.8 3695.7
2017 12273.9 2670.1